atenolol has been researched along with Long QT Syndrome in 20 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate effects of carvedilol (Akridilol, AKRIKHIN, Russia) on central hemodynamics, microvascular bed, hemorheology, von Willebrand factor (VWF) activity, clinical efficacy of the drug and influence on exercise tolerance in patients with Q myocardial infarction (QMI) compared to therapy with atenolol." | 9.11 | [Carvedilol in combined therapy of patients with Q myocardial infarction]. ( Iakovleva, MS; Mironova, MA; Sadionchenko, VS; Shekhian, GG, 2005) |
| "In order to dissociate the Class III effects of sotalol on QT interval and arrhythmias from those of chronic beta-receptor blockade, we compared the effects of sotalol 160 mg b." | 9.06 | A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction. ( Alexopoulos, D; Cobbe, PC; Cobbe, SM; Johnston, J; McCaie, CP; Winner, SJ, 1988) |
| "Twenty children and adolescents treated orally with atenolol for chronic paroxysmal ventricular tachycardia (n = 10) or Long QT Syndrome (n = 10) over a 5 year period were retrospectively evaluated to ascertain the efficacy of arrhythmia suppression, the effective dosage, the cardiovascular effects, and the incidence of adverse effects." | 7.68 | Atenolol in children with ventricular arrhythmias. ( Gillette, PC; Trippel, DL, 1990) |
| "To evaluate effects of carvedilol (Akridilol, AKRIKHIN, Russia) on central hemodynamics, microvascular bed, hemorheology, von Willebrand factor (VWF) activity, clinical efficacy of the drug and influence on exercise tolerance in patients with Q myocardial infarction (QMI) compared to therapy with atenolol." | 5.11 | [Carvedilol in combined therapy of patients with Q myocardial infarction]. ( Iakovleva, MS; Mironova, MA; Sadionchenko, VS; Shekhian, GG, 2005) |
| "In order to dissociate the Class III effects of sotalol on QT interval and arrhythmias from those of chronic beta-receptor blockade, we compared the effects of sotalol 160 mg b." | 5.06 | A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction. ( Alexopoulos, D; Cobbe, PC; Cobbe, SM; Johnston, J; McCaie, CP; Winner, SJ, 1988) |
| "Twenty children and adolescents treated orally with atenolol for chronic paroxysmal ventricular tachycardia (n = 10) or Long QT Syndrome (n = 10) over a 5 year period were retrospectively evaluated to ascertain the efficacy of arrhythmia suppression, the effective dosage, the cardiovascular effects, and the incidence of adverse effects." | 3.68 | Atenolol in children with ventricular arrhythmias. ( Gillette, PC; Trippel, DL, 1990) |
| "Levobupivacaine was substituted for routine racemic bupivacaine to decrease the risk of drug-induced cardiotoxicity." | 1.33 | Long QT syndrome: anaesthetic management at delivery. ( Behl, S; Wauchob, TD, 2005) |
| "Long QT syndrome is characterized by familial syncope and sudden death in the context of sudden heart rate changes." | 1.31 | Beta blockers normalize QT hysteresis in long QT syndrome. ( Chauhan, V; Hegele, RA; Klein, GJ; Krahn, AD; Skanes, AC; Wang, J; Yee, R, 2002) |
| "However, the incidence of sudden death and aborted sudden death (24% in all patients and 17% in compliant patients) strongly suggests the use of a "back-up" defibrillator, particularly in noncompliant adolescent patients." | 1.30 | Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. ( Belhassen, B; Dorostkar, PC; Eldar, M; Scheinman, MM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Zeitone, A | 1 |
| Peterson, DR | 1 |
| Polonsky, B | 1 |
| McNitt, S | 1 |
| Moss, AJ | 2 |
| Wong, JA | 1 |
| Gula, LJ | 1 |
| Klein, GJ | 2 |
| Yee, R | 2 |
| Skanes, AC | 2 |
| Krahn, AD | 2 |
| Moltedo, JM | 1 |
| Kim, JJ | 1 |
| Friedman, RA | 1 |
| Kertesz, NJ | 1 |
| Cannon, BC | 1 |
| Mikesell, CE | 1 |
| Atkinson, DE | 1 |
| Rachman, BR | 1 |
| Farhoumand, AD | 1 |
| Trombert, V | 1 |
| Eusebio, J | 1 |
| Hwang, SW | 1 |
| Thomas, JG | 1 |
| Whitehead, WE | 1 |
| Curry, DJ | 1 |
| Dauser, RC | 1 |
| Kim, ES | 1 |
| Luerssen, TG | 1 |
| Jea, A | 1 |
| Behl, S | 1 |
| Wauchob, TD | 1 |
| Sadionchenko, VS | 1 |
| Iakovleva, MS | 1 |
| Shekhian, GG | 1 |
| Mironova, MA | 1 |
| Murphy, I | 1 |
| Moneley, D | 1 |
| Kelly, D | 1 |
| Foley, B | 1 |
| Sheehan, S | 1 |
| Perry, GY | 1 |
| Kosar, EM | 1 |
| Majewski, J | 1 |
| Lelakowski, J | 1 |
| Dorostkar, PC | 1 |
| Eldar, M | 1 |
| Belhassen, B | 1 |
| Scheinman, MM | 1 |
| Zareba, W | 1 |
| Hall, WJ | 1 |
| Schwartz, PJ | 1 |
| Crampton, RS | 1 |
| Benhorin, J | 1 |
| Vincent, GM | 1 |
| Locati, EH | 1 |
| Priori, SG | 1 |
| Napolitano, C | 1 |
| Medina, A | 1 |
| Zhang, L | 1 |
| Robinson, JL | 1 |
| Timothy, K | 1 |
| Towbin, JA | 1 |
| Andrews, ML | 1 |
| Furushima, H | 1 |
| Chinushi, M | 1 |
| Washizuka, T | 1 |
| Aizawa, Y | 1 |
| Raviña, T | 1 |
| Lapuerta, JA | 1 |
| Brugada, J | 1 |
| Chauhan, V | 1 |
| Wang, J | 1 |
| Hegele, RA | 1 |
| Chien, WW | 1 |
| Foster, E | 1 |
| Phillips, B | 1 |
| Schiller, N | 1 |
| Griffin, JC | 1 |
| Trippel, DL | 1 |
| Gillette, PC | 1 |
| Cobbe, SM | 1 |
| Alexopoulos, D | 1 |
| Winner, SJ | 1 |
| McCaie, CP | 1 |
| Cobbe, PC | 1 |
| Johnston, J | 1 |
| Rynkiewicz, A | 1 |
| Rossi, P | 1 |
| Yusuf, S | 1 |
| Sleight, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Long QT Syndrome-Population Genetics and Cardiac Studies[NCT00005176] | 2,125 participants (Actual) | Observational | 1985-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for atenolol and Long QT Syndrome
| Article | Year |
|---|---|
Prolonged QT syndrome and sedation: a case report and a review of the literature.
Topics: Arrhythmias, Cardiac; Atenolol; Child, Preschool; Conscious Sedation; Electrocardiography; Emergency | 2011 |
6 trials available for atenolol and Long QT Syndrome
| Article | Year |
|---|---|
Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Electrocardiography; ERG1 Potassium Channe | 2010 |
[Carvedilol in combined therapy of patients with Q myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Atenolol; Carbazoles; Carvedilol; Drug | 2005 |
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Female; Humans; I | 2000 |
Role of alpha1-blockade in congenital long QT syndrome: investigation by exercise stress test.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-A | 2001 |
A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atenolol; Cardiac Complexes, Premature; Clinical Trials as Topic; | 1988 |
[Effect of atenolol on the QT interval in the acute phase of myocardial infarction].
Topics: Adult; Aged; Arrhythmias, Cardiac; Atenolol; Clinical Trials as Topic; Female; Humans; Long QT Syndr | 1988 |
13 other studies available for atenolol and Long QT Syndrome
| Article | Year |
|---|---|
Efficacy of different beta-blockers in the treatment of long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Death, Sudden, Ca | 2014 |
Use of a cardioselective beta-blocker for pediatric patients with prolonged QT syndrome.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Atenolol; Child; Child, Preschool; Female; Heart | 2011 |
[Practical ECG problems in the elderly patient. Case number 16. Moxifloxacin-associated QT interval prolongation].
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Infective Agents; Atenolol; Aza Compounds; Bradycard | 2011 |
Left thorascopic sympathectomy for refractory long QT syndrome in children.
Topics: Adolescent; Adrenergic beta-Antagonists; Atenolol; Cardiac Surgical Procedures; Child; Child, Presch | 2011 |
Long QT syndrome: anaesthetic management at delivery.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Analgesics, Opioid; Anesthetics, Local; Anti-Arr | 2005 |
Endoscopic thoracic sympathectomy for long QT syndrome.
Topics: Adrenergic beta-Antagonists; Atenolol; Defibrillators, Implantable; Electric Countershock; Female; H | 2008 |
Problems in managing patients with long QT syndrome and implantable cardioverter defibrillators: a report of two cases.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Defibrillators, Implantable; Electrocardiography; Fema | 1996 |
[Hereditary long QT syndrome: our own experience].
Topics: Adolescent; Adrenergic beta-Antagonists; Atenolol; Electrocardiography; Female; Humans; Long QT Synd | 1999 |
Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child; Child, Preschool; Cohort Stud | 1999 |
Prolonged repolarization in long QT3 syndrome: unusual electrocardiographic findings.
Topics: Anti-Arrhythmia Agents; Atenolol; Child; Defibrillators, Implantable; Electrocardiography; Humans; L | 2002 |
Beta blockers normalize QT hysteresis in long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Anti-Arrhythmia Agents; Atenol | 2002 |
Pacemaker syndrome in a patient with DDD pacemaker for long QT syndrome.
Topics: Atenolol; Echocardiography; Electrocardiography; Heart Rate; Humans; Long QT Syndrome; Male; Middle | 1991 |
Atenolol in children with ventricular arrhythmias.
Topics: Adolescent; Arrhythmias, Cardiac; Atenolol; Cardiovascular System; Dose-Response Relationship, Drug; | 1990 |